Thomas J. Schall

Insider Reports History

Location
Mountain View, CA
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Thomas J. Schall
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas J. Schall:

Company Role Class Num Shares Value Price $ Report Date Ownership
Immuneering Corp Director Class A Common Stock 52,885 $193,659 $3.66 27 Jun 2025 Direct
Immuneering Corp Director Stock Option 33,350 13 Jun 2025 Direct
ChemoCentryx, Inc. President and CEO, Director Common Stock 0 $50.95 20 Oct 2022 Direct
ChemoCentryx, Inc. President and CEO, Director Restricted Stock Unit 0 20 Oct 2022 Direct
ChemoCentryx, Inc. President and CEO, Director Stock Option 0 20 Oct 2022 Direct

Insider Reports Filed by Thomas J. Schall

Symbol Company Period Transactions Value $ Form Type Role Filing Time
IMRX Immuneering Corp 27 Jun 2025 1 +$34,788 4 Director 30 Jun 2025, 09:09
IMRX Immuneering Corp 17 Jun 2025 1 +$89,278 4 Director 18 Jun 2025, 09:11
IMRX Immuneering Corp 13 Jun 2025 1 $0 4 Director 16 Jun 2025, 09:15
IMRX Immuneering Corp 12 Jun 2024 1 $0 4 Director 13 Jun 2024, 16:26
IMRX Immuneering Corp 22 Mar 2024 1 +$7,385 4 Director 25 Mar 2024, 16:03
IMRX Immuneering Corp 11 Mar 2024 1 $0 4 Director 12 Mar 2024, 17:02
IMRX Immuneering Corp 11 Mar 2024 0 $0 3 Director 12 Mar 2024, 08:31
CCXI ChemoCentryx, Inc. 20 Oct 2022 20 $0 4 President and CEO, Director 24 Oct 2022, 19:01
CCXI ChemoCentryx, Inc. 04 Aug 2022 3 -$4,675,333 4 President and CEO, Director 08 Aug 2022, 19:41
CCXI ChemoCentryx, Inc. 22 Feb 2022 2 $0 4 President and CEO, Director 25 Feb 2022, 19:39
CCXI ChemoCentryx, Inc. 01 Jan 2022 7 -$1,663,864 4 President and CEO, Director 04 Jan 2022, 20:42
CCXI ChemoCentryx, Inc. 01 Dec 2021 4 +$499,994 4 President and CEO, Director 03 Dec 2021, 18:39